Cargo Therapeutics
Founded 2019 · CIK 0001966494 · Biotech · Acquired
CAR-T cell immunotherapy engineered with 4-1BB costimulation domain for B cell lymphoma treatment
cargotx.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $69M
- 1 Form D · Mar 2023
- 43 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 27
- 0 granted · 27 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20222023
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $68,832,003 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1949 | GENECENTRIX INC. | — | — |
| 1950 | SCALED MICROBIOMICS, LLC | — | — |
| 1951 | RYLTI, LLC | — | $2.3M |
| 1952 | Cargo Therapeutics | — | $69M |
| 1953 | Plex Pharmaceuticals, Inc. | — | — |
| 1954 | Caring Brands, Inc. | — | $1.8M |
| 1955 | KIBIO INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Abraham BassanDirector
- Gina ChapmanDirector · Executive Officer
- Cassandra Gianna LucaDirector
- Heath LukatchDirector
- Crystal MackallDirector
- John OrwinDirector
- Anup RadhakrishnanExecutive Officer
- Krishnan ViswanadhanDirector
- Jeffrey WalshDirector
Patents
- Methods For Manufacturing Car T Cellsapplication
- Compositions And Methods For Allogeneic Immune Cellsapplication
- Compositions And Methods For Allogeneic Immune Cellsapplication
- Methods For Manufacturing Car T Cellsapplication
- Modified Immune Effector Cellsapplication
- Methods For Manufacturing Car T Cellsapplication
- Compositions And Methods For Immunotherapiesapplication
- ANTI-CD22 Chimeric Antigen Receptor (car) Therapiesapplication
- Compositions And Methods For Allogeneic Immune Cellsapplication
- Compositions And Methods For Immunotherapiesapplication
- Multiplex Cell Selection Compositions And Uses Thereofapplication
- Compositions And Methods For Immunotherapiesapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.